Seven Powers Framework
Diagnose whether a company's edge is real and durable, or just a temporary lead.
- Difficulty
- Advanced
- Time to result
- ~ongoing to results
- Steps
- 7
- Confidence
- 90%
Borrowed from Hamilton Helmer's book '7 Powers,' this is a mental model for identifying the specific mechanism that lets a company earn persistent, differential profits versus competitors. Rather than assuming size, margins, or market share equal a moat, the framework forces you to check for one of seven distinct sources of durable advantage: counter-positioning, scale economies, switching costs, network economies, process power, branding, and cornered resource. Applied to Novo Nordisk, the hosts find strong cornered resource (patents), scale economies (R&D and manufacturing costs), switching costs, process power, and even brand power around Ozempic, while counter-positioning and network economies are largely absent or debatable.
Origin
Developed by strategist Hamilton Helmer in his book '7 Powers'; the Acquired hosts use it as a recurring lens for closing out every company deep-dive.
Core principles
- 01Profits without an identifiable 'power' behind them are usually temporary
- 02Counter-positioning is a launch-phase advantage that incumbents rarely retain long-term
- 03Multiple compounding powers create the deepest, most durable defensibility
- 04Scale alone is not a moat unless it changes unit economics versus competitors
How to run it
- 1
Check for Counter-Positioning
Determine whether the company has a business model that rivals could copy but choose not to because it would damage their existing business.
Watch out This power almost always fades once the industry matures.
- 2
Assess Scale Economies
Look at whether fixed costs (R&D, manufacturing, go-to-market) are so large that only the biggest players can operate profitably.
Pro tip In pharma, check R&D cost per approved drug ($2.3B on average) as a scale barrier.
- 3
Evaluate Switching Costs
Assess how costly or risky it is for a customer to move to a competitor once they've adopted the product.
- 4
Look for Network Economies
Check whether the product becomes more valuable to each user as more people use it, versus just benefiting from word-of-mouth.
Pro tip Be skeptical: strong word-of-mouth marketing is often mistaken for a true network effect.
- 5
Identify Process Power
Look for proprietary operational know-how built up over years or decades that is hard for a newcomer to replicate quickly.
- 6
Evaluate Branding
Determine if the company can charge more or be preferentially chosen purely because of accumulated trust and recognition in its name.
- 7
Identify Cornered Resource
Check whether the company has exclusive, hard-to-replicate access to a critical asset such as a patent, unique talent, or proprietary data.
Pro tip In patent-driven industries like pharma, this is often the single most important power to check first.
In the wild
Novo Nordisk holds the patent on semaglutide until 2032, giving it a legally cornered resource on the molecule behind Ozempic and Wegovy, while its century of accumulated manufacturing know-how in peptide chemistry adds process power on top.
→ Novo Nordisk became one of the most profitable pharma companies in the world despite intense competitive interest in the GLP-1 category.
AbbVie's Humira generated roughly $200 billion in lifetime sales by getting approved across 11 different indications, showing how a single cornered-resource drug with scale economies in trials and manufacturing can dominate for over a decade.
→ Sustained blockbuster profitability even without a deep pipeline of other drugs.
Common mistakes
Assuming size equals moat
Large revenue or market share doesn't guarantee a power exists; without a specific mechanism protecting margins, competitors can still erode returns over time.
Confusing launch-phase advantage with permanence
Counter-positioning is real early on, but incumbents almost never retain a counter-positioning advantage once the market matures; treating it as durable overstates a moat.
Mislabeling word-of-mouth as network economies
A product that spreads because users become visible 'walking billboards' isn't the same as a true network effect where the product itself gets better as more people join.
Is it for you?
Best for
Analysts, investors, and operators evaluating whether a company's profits are structurally durable
Not ideal for
Very early-stage startups pre-product-market-fit, where none of the seven powers have had time to form
From the transcript
“this is borrowed from our great friend Hamilton Helmer and his wonderful book Seven powers where he talks about the means by which a company…”
“the seven powers are counter positioning scale economies switching costs Network economies process power branding and cornered resource”
“counter positioning basically always exists in the takeoff phase and never exists later”
From the episode
Novo Nordisk (Ozempic)